Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Device Recalls / Medtronic Sofamor Danek USA INC

QualityClass II recall21 Oct 2026

Medtronic Sofamor Danek USA INC

21 Oct 2026: Class II recall · Grafton" DBM and Grafton Plus" DBM contain demineralized human bone tissue combined with an inert additive to yield a demineralized bone matrix (DBM) allograft . Recorded in the openFDA device enforcement reports.

View the source record

Reported
21 Oct 2026
Recall Class
Class II
Product
Grafton" DBM and Grafton Plus" DBM contain demineralized human bone tissue combined with an inert additive to yield a demineralized bone matrix (DBM) allograft
Reason
Medtronic identified through donor record review that the donor for Medtronic batch A62881 did not meet all Medtronic donor eligibility requirements related to the presence of microbial organisms. While the batch passed finished product ste
Country
United States
Status
Ongoing
Reference
Z-0137-2027
Location
Memphis, TN
What this signal means

A recall puts quality, regulatory, field service and communications under pressure at once.

  1. Class II leads with 660 of 741, then Class I (68).
  2. 235 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Medtronic Sofamor Danek USA INC

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.

Start free

Across AOS Research

Other records for Medtronic Sofamor Danek USA INC in our registers.

More in Class II

Device Recalls

See all

Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.